Kidney Health

The Kidney Health - Basic panel is a crucial set of tests designed to evaluate kidney function and overall health. This panel comprises a Complete Blood Count with Differential and Platelets, a Comprehensive Metabolic Panel, and a Urinalysis Complete. These tests offer a comprehensive look at the body's filtration system, checking for signs of kidney disease, infection, and other potential health issues.

The Kidney Health - Basic Plus panel is an enhanced diagnostic tool designed to provide a deeper insight into kidney function and overall health status. It includes a Complete Blood Count with Differential and Platelets, a Comprehensive Metabolic Panel, PTH Intact, Uric Acid, and a Urinalysis Complete. This panel provides a broad overview of blood health, metabolic function, and specifically, kidney health.

The Kidney Health - Advanced panel is an extensive diagnostic tool designed for a detailed assessment of kidney function and related health indicators. It encompasses a Complete Blood Count with Differential and Platelets, a Comprehensive Metabolic Panel, Random Urine Creatinine, PTH Intact, QuestAssureD 25-Hydroxyvitamin D Total with D2 and D3, Uric Acid, and a Urinalysis Complete. This panel offers a comprehensive look at the body's filtration system, checking for signs of kidney disease, vitamin D status, and other potential health issues.

The Kidney Health - Comprehensive panel is the most extensive evaluation offered for assessing kidney function and related health indicators. This panel includes an ANA Screen, IFA with Reflex to Titer and Pattern, a Complete Blood Count with Differential and Platelets, a Comprehensive Metabolic Panel, Random Urine Creatinine, PTH Intact, QuestAssureD 25-Hydroxyvitamin D Total with D2 and D3, Uric Acid, and a Urinalysis Complete. It provides a detailed look at kidney function, autoimmune indicators, metabolic health, and vitamin D status.

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

The Urinalysis Complete Test evaluates urine for physical, chemical, and microscopic properties to assess kidney health, urinary tract infections, diabetes, and metabolic disorders. It measures appearance, concentration, pH, protein, glucose, ketones, blood, bilirubin, nitrites, leukocyte esterase, and microscopic cells or crystals. Doctors use this test in routine exams, to diagnose urinary symptoms, and to monitor chronic kidney or metabolic disease.

The Basic Metabolic Panel (BMP) Test measures eight markers, including glucose, calcium, sodium, potassium, chloride, carbon dioxide, BUN, and creatinine, to evaluate kidney function, blood sugar, and electrolyte balance. Doctors use this panel to detect diabetes, dehydration, and kidney disease, or to monitor treatment. It is commonly ordered in routine exams, emergency care, or pre-surgical testing to assess overall metabolic and organ health.

The Urinalysis Complete Test with Reflex to Culture screens urine for abnormalities in color, clarity, pH, protein, glucose, ketones, blood, and microscopic elements like red and white cells. If infection is suspected, it reflexes to a urine culture to identify bacteria. Doctors use this test to detect urinary tract infections (UTIs), kidney disease, diabetes, and metabolic disorders, guiding accurate diagnosis, treatment, and ongoing health management.

The Culture Urine Routine Test detects and identifies bacteria or yeast in urine that cause urinary tract infections (UTIs). By growing microorganisms in a lab, this test determines the type of infection and guides effective treatment. Doctors use it to evaluate symptoms such as painful urination, frequent urges, or fever and to monitor recurrent UTIs. Results provide critical insight for diagnosis, antibiotic selection, and urinary health management.

The Albumin Test measures albumin, the main protein made by the liver that maintains fluid balance and transports hormones, vitamins, and medications. Low albumin may indicate liver disease, kidney problems, malnutrition, or chronic inflammation, while high levels may reflect dehydration. Doctors order this test to evaluate swelling, fatigue, or abnormal labs. Results provide key insight into nutritional status, liver and kidney function, and overall metabolic health.

The Creatinine Test measures creatinine levels in blood to evaluate kidney function and filtration efficiency. Elevated levels may indicate kidney disease, dehydration, or muscle disorders, while low levels may reflect reduced muscle mass. Doctors use this test to monitor chronic kidney disease (CKD), assess treatment response, and detect early signs of renal impairment. It provides key insight into kidney health, metabolic balance, and overall renal function.

The Cystatin C Test with eGFR measures blood levels of cystatin C, a protein filtered by the kidneys, and calculates estimated glomerular filtration rate (eGFR). This test provides a sensitive marker for kidney function and can detect early kidney disease, even when creatinine levels are normal. Doctors order it to evaluate chronic kidney disease risk, monitor treatment, and assess overall kidney health in patients with diabetes, hypertension, or other conditions.

The Early Sjögren’s Syndrome Profile tests for antibodies to carbonic anhydrase VI (CA VI), salivary protein 1 (SP-1), and parotid specific protein (PSP) across IgG, IgA, and IgM isotypes. These novel biomarkers may appear before classic SS-A/SS-B antibodies, helping identify Sjögren’s syndrome earlier. This profile supports assessment of early autoimmune damage to salivary and lacrimal glands.

The Kappa/Lambda Light Chains, Free with Ratio Blood Test measures free kappa and lambda light chains, proteins produced by plasma cells, and calculates their ratio. Abnormal results may indicate multiple myeloma, light chain amyloidosis, or related plasma cell disorders. Doctors use this test with serum protein electrophoresis and immunofixation to detect, diagnose, and monitor disease progression or treatment response in patients with suspected blood cancers.

The Lactate Dehydrogenase (LDH) Isoenzyme Panel measures total LDH and separates it into isoenzymes (LDH-1 to LDH-5) to identify tissue damage. LDH-1 is linked to heart, LDH-2 to blood, LDH-3 to lungs, LDH-4 to kidneys, and LDH-5 to liver and muscle. Elevated levels may indicate heart attack, liver disease, anemia, or cancer. Doctors order this test to pinpoint tissue injury, monitor disease progression, and guide treatment strategies.

The Lipid Panel Test with Reflex to Direct LDL measures total cholesterol, HDL, LDL, triglycerides, and cholesterol ratios to assess heart and vascular health. If triglycerides are very high, it automatically reflexes to direct LDL measurement for greater accuracy. Doctors use this test to evaluate cardiovascular risk, guide cholesterol management, and monitor therapy. Results provide key insight into lipid balance, heart disease prevention, and metabolic health.

The LKM-1 IgG Antibody Test measures antibodies targeting liver kidney microsomal antigen 1, often linked to autoimmune hepatitis type 2 and liver dysfunction. It helps identify autoimmune activity, chronic hepatitis, and unexplained liver inflammation. This test provides valuable information about immune response, hepatic health, and systemic risks related to autoimmune-mediated liver disease.

The Albumin Creatinine Ratio Timed Urine Test measures albumin and creatinine levels in a timed urine sample to evaluate kidney function. Elevated albumin excretion can indicate early kidney damage, diabetic nephropathy, or hypertension-related disease. By analyzing the albumin-to-creatinine ratio, this test provides insight into kidney filtration, urinary protein loss, and overall renal health monitoring.

The Oxalic Acid 24 Hour Urine Test measures urinary oxalate excretion to evaluate risk for kidney stone formation and metabolic disorders. Elevated oxalic acid may indicate primary or secondary hyperoxaluria, malabsorption syndromes, or dietary imbalance. By tracking oxalate output over 24 hours, this test provides valuable insight into urinary health, metabolic function, and conditions that impact calcium oxalate stone development.

The Oxalic Acid Random Urine Test measures urinary oxalate levels to evaluate risk of kidney stone formation and metabolic disorders. Elevated oxalate may result from dietary factors, intestinal malabsorption, or primary hyperoxaluria, while low levels may reflect dietary deficiency or altered metabolism. This test supports assessment of urinary chemistry, renal health, and metabolic balance in stone disease evaluation.

The PBC Diagnostic Panel detects autoantibodies associated with primary biliary cholangitis, including AMA (with reflex titer), ANA (IFA with pattern), SMA (IgG), SSA/SSB, TPO, and LKM-1. By assessing a comprehensive autoimmune profile, this panel aids differentiation of PBC from overlapping autoimmune liver or systemic conditions and supports accurate diagnosis in suspected cholestatic disease.